Immunocore Holdings's total assets for Q4 2024 were $1.01B, a decrease of -6.93% from the previous quarter. IMCR total liabilities were $648.79M for the fiscal quarter, a -8.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.